Table 1.
MS risk factor | Risk* | Observations | Postulated mechanism | Alternative mechanism | |
---|---|---|---|---|---|
|
|
|
|
1. Compromise of MS-protective immune reactions favouring the biosynthesis of MLN |
|
Human endogenous retrovirus-W (HERV-W) |
X |
F |
HERV-W and/or syncytin-1 more frequently detectable/elevated in MS, increased levels of antibodies against HERV GAG and ENV antigens in MS, related to the activity of disease [4-8] |
Overexpression of the syncytin-1 gene encoded by HERV-W disturbs redox regulation in glial cells [9] |
|
Time in life of infection |
E●●● |
P |
Virtually all MS patients experienced previous EBV-infection and had elevated levels of anti- EBV-EBNA1 antibody in comparison with control groups [3,10,11]. Previous EBV-infection years or decade(s) before onset of MS [12]. Expanded T-helper cell populations recognizing an epitope of the EBV antigen EBNA1 in MS patients [13] |
Infection with EBV early in life can establish MS protective immunity [3,10,11,14]. Infection with EBV delayed in life after immune response against an epitope nested in FENIAEGLRALLARSHVER (partial sequence of EBNA-1) is primed (see next entry) to form T- helper cells instead of regulatory T-cells essential for MS protection [14] |
(Irrespective of time in life): Clonal expansion of lymphocytes in the CNS, or EBV infection triggers autoimmunity via molecular mimicry |
with Epstein-Barr virus (EBV) |
§ |
||||
E |
F |
||||
Involvement of infection with measles, varicella and herpes simplex viruses and with 12 or more other pathogens |
E●●● |
P |
Higher antibody-levels against diverse pathogens in particular measles, varicella, herpes simplex viruses, and EBV in MS-patients [10,15,16], intrathecal synthesis of antibodies against these viruses (including as in particular also rubella virus) [17,18] |
Immune responses against diverse agents generates MS-protection by cross-reaction of a self-specific CD8+-T-cell response against a peptide MPVPSAPSTMPVPSAPST belonging to the human endogenous retrovirus W (HERV-W), encoded on the complementary DNA-strand of the syncytin-1 gene [14,19] |
Immunological trigger for inflammatory demyelination |
§ | |||||
§ | |||||
Infection with Chlamydia pneumoniae and/or human herpes virus-6 |
E § |
F |
More frequent detection of genomes of these agents in MS [15,20,21] More frequent IgM-specific antibodies against Chlamydia pneumoniae in paediatric onset MS [15] |
Persisting infections can prime immune response against an epitope nested in FENIAEGLRALLARSHVER (partial sequence of EBV EBNA-1) to induce T-helper cells [14] |
|
Worm infestation |
E●● |
P |
Worm infestation less frequent in MS and treatment of worm infections leads to relapse of MS [22] |
Contributes an immune stimulatory context that favours the generation of regulatory T-cells |
|
Antihistamines |
E w |
P |
Protective effects of antihistamines in MS [23] |
Antihistamines suppress unfavourable allergic reactions competing with 'anti-parasite’-like reactions |
|
HLA-polymorphism |
G |
P |
Main HLA class I molecule A*0201 for the HLA-A0201 associated with a significantly reduced MS risk (OR = 0.52, P = 0.0015) [24] |
Ability of HLA-polymorphism for immune presentation of the peptide MPVPSAPSTMPVPSAPST is good such as with HLA-A0201 (frequency of about 30% in a European population) [14] |
See the text |
Interleukin-2 receptor α (IL-2Rα) |
G |
P |
Mutations in IL-2Rα gene in MS more frequent [25] |
Component of the CD-25 molecule of regulatory T-cells, critical involvement of these cells in MS-protection |
|
Interleukin-7 receptor α (IL-7Rα) |
G |
P |
Mutations in IL-7Rα gene in MS more frequent [26] |
Important for maintenance of CD8+-T-cell memory, critical is a long-persisting MS-protective cellular immune reaction |
|
n-3-polyunsaturated fatty acids |
E |
P |
Reduced MS risk with diet rich in n-3 poly-unsaturated fatty acids [27] |
Dietary factors leading to an enrichment of ganglioside-content of T-cells. The MS-protective immune reaction seems to be an immune repair mediated by gangliosides [14,19,28,29] |
|
|
|
|
|
2. Factors favouring the biosynthesis of MLN not predominantly involving the immune system |
|
Vitamin D-deficiency |
E●●● § |
F |
Month of birth-effect [30,31]. Low levels of vitamin D in MS patients [32-34] |
Deficiency pre-birth and after birth reduces intracellular glutathione [35] |
Levels of vitamin D experienced in utero can have long-lasting effects on the development of numerous organ systems, including the CNS; during life, vitamin D has clear immunomodulatory functions |
Low sun exposure |
E●● |
F |
Influence of place of residence, MS risk increases with higher latitude [3,32] |
Reduced exposure to sunlight rich in UV-B dependent on geographical latitude [3,32] |
|
Selenium deficiency |
E w |
F |
MS more frequent in regions with low levels of selenium in soil [36,37] |
Selenium deficiency reduces levels of the seleno-enzyme glutathione-peroxidase [38] |
|
Female sex hormones |
E § |
F |
Dependence of MS risk on gender. MS risk in young children indepedent from gender but increased girl/boy rate in puberty [31,32]. Reduced MS risk in pregnancy, elevated MS risk after pregnancy and after the menopause [39] |
Syncytin-1 gene has a sensitivity for female sex hormones, (gene product has physiological role in placenta) [39] |
Altered antigen reactivity, tolerance, epigenetic effects |
Smoking |
E●● |
F |
Higher risk of MS in cigarette smokers [40] |
Nicotine accumulates in melanin containing cells and interferes with melanin synthesis [41] |
Nitric oxide-mediated demyelination, axonal loss and epigenetic effects |
Iron-load |
E |
F |
MS association to eating of meat [27]. Iron accumulation early in MS plaques [42,43] |
Melanoma-melanin is incorporating iron [44-48] |
|
|
|
|
|
3. Oxidative charging of MLN |
|
Vitamin D-deficiency |
E●●● |
F |
See above |
See above, glutathione is needed for discharging of MLN |
|
§ | |||||
Low sun exposure |
E●● |
F |
See above |
See above, glutathione is needed for discharging of MLN |
|
Selenium deficiency |
E w |
F |
See above |
See above, glutathione-peroxidase is needed for discharging of MLN Iron containing MLN is charged by ionizing radiation/ cosmic radiation [49]. Cosmic radiation |
|
Geomagnetic disturbances/ Cosmic radiation |
E●● |
F |
MS relates to geomagnetic 60° latitude [1] |
||
E |
F |
MS association to mountain regions [50] |
|||
|
|
|
|
4. Physiological influence on activity of neuromelanin |
|
Visible light |
E § |
P |
Increased risk of MS onset (1st attack) in the lightest months of the year [31,51] |
The hormone melatonin regulates the daily activity of neuromelanins (light-triggered day-night rhythm) |
|
|
|
|
|
5. Formation of short living reactive oxygen species and radicals (ROS) by mitochondria |
|
Psycho-physical trauma |
E |
F |
Increased MS risk in relations to psycho-physical trauma, detection of ROS-related products in MS [52] |
Traumatic events lead to the generation of ROS by mitochondria |
Dysregulation of the hypothalamic-pituary-adrenal axis |
Heat/fever |
E |
F |
Heat as attack provoking factor in MS [53,54] |
Heat leads to the generation of ROS by mitochondria |
|
|
E |
F |
MS protective effect of the introduction of anti-pyretics [53] and of the antibiotic penicillin [55] |
Fever leads to the generation of ROS by mitochondria |
|
Chronic stress reaction |
E w |
F |
Decreased ubiquinone, and increased endogenous digoxin and metabolites of oxidative stress in MS [56] |
Over-activation of the cellular mevalonate pathway with decrease of ubiquinone, and increase of endogenous digoxin and ROS production by mitochondria [56] |
As above |
|
|
|
|
6. Formation of long-living reactive oxygen species and radicals (ROS) requiring typically nitrogen oxide as a co-substrate |
|
Infection/Inflammation |
E |
F |
A small blood vessel is often running through the plaque, the end stage of MS pathology [57] |
Adherent polymorph nuclear cells in small blood vessels form nitrogen oxide (NO) that is not readily cleared |
|
Gout |
E |
P |
MS is extremely rare in patients with gout and levels of uric acid are about 10 to 15% lower in patients with MS [58] |
Radical scavenger function of uric acid for nitrogen-containing ROS [58] |
|
decreased uric acid |
E |
F |
|||
Glatiramer-acetate | E | P | An agent with therapeutic benefit in MS | Inhibition of NO synthase of mononuclear cells [59] |
Categorization of risks (see footnotes), observations, postulated mechanisms with respect to a hypothetical melanoma-like neuromelanin (MLN) ordered in groups of 6 aspects, and alternative mechanisms as suggested in ref [32].
* E = environmental risk, G = genetic risk, X = genetic factor but indirectly environmental risk; P = protective, F = fatal; ●●● = very strong evidence; ●● = strong evidence; w = evidence weak. § In a group of German patients with onset of MS in childhood, studied by Hanefeld and co-workers, diverse observations were made more or less in the same study group. Categorization for the evidence of these observations is based on comparison of p-values by multiple testing with Bonferroni-correction as described in ref. [15].